CD56(bright) natural killer cells expand and contract irrespective of CD25 antibody treatment in kidney allograft recipients

Scand J Immunol. 2009 May;69(5):465-7. doi: 10.1111/j.1365-3083.2009.02236.x. Epub 2009 Feb 6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / pharmacology*
  • CD56 Antigen / immunology*
  • Female
  • Humans
  • Interleukin-2 Receptor alpha Subunit / immunology*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / methods
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Time Factors
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal
  • CD56 Antigen
  • Interleukin-2 Receptor alpha Subunit